| Current dividend yield | 4.9 % |
| Dividendenrendite 5 Jahre | 3.96 % |
| Dividend Yield 10Y | 4.25 % |
| Payout 3Y | 5.54 % |
The Luye Pharma Group stock dividend is paid 2 times a year. In order to receive a dividend, you should generally own the Luye Pharma Group stock before the ex-dividend date. The Dividend Calendar shows that the ex-day dates were last at and . Dividends from Luye Pharma Group are distributed via and .
| Year | Dividend | Ex-day & Payday |
Frequency | |
|---|---|---|---|---|
| Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
| 2020 |
HK$0.06
HK$0.06
|
Jun 29 2020
Jun 29 2020
Jul 31 2020
Jun 29 20
Jul 31 20 |
Jul 31 2020 |
semi annual
semi-annual
|
| 2019 |
HK$0.067
HK$0.07
|
Sep 09 2019
Sep 09 2019
Sep 30 2019
Sep 09 19
Sep 30 19 |
Sep 30 2019 |
semi annual
semi-annual
|
| 2019 |
HK$0.065
HK$0.07
|
Jun 14 2019
Jun 14 2019
Jul 18 2019
Jun 14 19
Jul 18 19 |
Jul 18 2019 |
semi annual
semi-annual
|
| 2018 |
HK$0.051
HK$0.05
|
Sep 06 2018
Sep 06 2018
Sep 28 2018
Sep 06 18
Sep 28 18 |
Sep 28 2018 |
semi annual
semi-annual
|
| 2018 |
HK$0.054
HK$0.05
|
Jun 14 2018
Jun 14 2018
Jun 29 2018
Jun 14 18
Jun 29 18 |
Jun 29 2018 |
semi annual
semi-annual
|
| 2017 |
HK$0.033
HK$0.03
|
Oct 04 2017
Oct 04 2017
Nov 08 2017
Oct 04 17
Nov 08 17 |
Nov 08 2017 |
semi annual
semi-annual
|
| 2017 |
HK$0.039
HK$0.04
|
Jun 15 2017
Jun 15 2017
Jul 18 2017
Jun 15 17
Jul 18 17 |
Jul 18 2017 |
semi annual
semi-annual
|
| 2016 |
HK$0.037
HK$0.04
|
Oct 04 2016
Oct 04 2016
Nov 08 2016
Oct 04 16
Nov 08 16 |
Nov 08 2016 |
semi annual
semi-annual
|
Luye Pharma Group most recently paid a dividend of HK$0.06. Luye Pharma Group paid a Dividend of HK$0.00 Per Share in the financial year 2025. With a stock price of HK$1.70 at Sep 17 2026, the current dividend yield is 0.00% (calculation: HK$0.00 / HK$1.70 = 0.00%). No special dividend was paid.
The average Luye Pharma Group dividend yield over the last 5 years is 0.00% and the average over the last 10 years is 0.91%.
The payout ratio of Luye Pharma Group in relation to the last financial year is 0.00%. The payout ratio smoothed over 3 years is 0.00%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
| Metric | Luye Pharma Group |
|---|---|
| Current dividend yield | 0.00% |
| Dividend Yield 5Y | 0.00% |
| Dividend Yield 10Y | 0.91% |
| Payout 1Y | 0.00% |
| Payout 3Y | 0.00% |
Luye Pharma Group has been paying a dividend for 0 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.
The average Luye Pharma Group Dividend Growth over the last 5 years is -100.00%.
| Metric | Luye Pharma Group |
|---|---|
| Increased | 0 Years |
| Continuity | 0 Years |
| Paid | 0 Years |
| Growth 5Y | -100.00% |
Luye Pharma Group has been paying a dividend for 0 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.
The average Luye Pharma Group Dividend Growth over the last 5 years is -100.00%.
On the stock exchange, the Luye Pharma Group stock (ISIN: BMG570071099) is not traded as a top scorer in September 2026 according to the dividend strategy.
The stock price of Luye Pharma Group -36.13% has fallen since the beginning of the year 2026. However, the return generated in the past says nothing about the future return. You can find the Luye Pharma Group stock price in real time at the top of the page.
Luye Pharma Group (symbol: 2186) is valued at a Price / Earnings Ratio (P/E ratio) of 13.08 and a price/sales ratio (P/S ratio) of 0.94 valued. Based on analyst estimates, the Luye Pharma Group stock forecast 2026 of the current financial year corresponds to a valuation of 8.12 according to P/E ratio and 0.94 according to P/S.
| Metric | Luye Pharma Group |
|---|---|
| Dividend Score | ??/15 |
| Performance 2026 |
36.13%
|
| P/E TTM | 13.08 |
| P/S TTM | 0.94 |
| P/E forward | 8.12 |
| P/S forward | 0.94 |
Luye Pharma Group (symbol: 2186) is valued at a Price / Earnings Ratio (P/E ratio) of 13.08 and a price/sales ratio (P/S ratio) of 0.94 valued. Based on analyst estimates, the Luye Pharma Group stock forecast 2026 of the current financial year corresponds to a valuation of 8.12 according to P/E ratio and 0.94 according to P/S.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


